Challenges of Cancer Drug Design A Drug Metabolism Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|1|1|1-32

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.1, Iss.1, 2001-05, pp. : 1-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Metabolism and Pharmacokinetics in Support of Drug Design

By  

Current Pharmaceutical Design, Vol. 15, Iss. 19, 2009-07 ,pp. : 2170-2183

Bentham Science Publishers

Access to resources Recommend Favorite

Organotypic systems in drug metabolism and toxicity: challenges and opportunities

By Dash Ajit   Blackman Brett R   Wamhoff Brian R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 999-1014

Informa Healthcare

Access to resources Recommend Favorite

The Role of the Intestine in Drug Metabolism and Pharmacokinetics: An Industry Perspective

By  

Current Drug Metabolism, Vol. 8, Iss. 7, 2007-10 ,pp. : 694-699

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges in Pediatric Drug Development: A Pharmaceutical Industry Perspective

By Rose Klaus  

Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. : 57-59

Adis International

Access to resources Recommend Favorite

DNA Drug Design for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2811-2823

Bentham Science Publishers

Access to resources Recommend Favorite